← Leaderboards
Maziar Divangahi
Washington University
$989,249
Attributed
$2,967,748
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $600K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,967,748 · 1
By mechanism
U01$2,967,748 · 1
Top collaborators
- Deepak Kaushal5 shared
- Shabaana A. Khader5 shared
Most similar at Washington University
Same institution · by research overlap
- Sean P. J. Whelan$36,954,740
- Ali Hassan Ellebedy$14,119,121
- Jai Rudra$4,772,528
- Marco Colonna$45,277,211
- Jennifer A Philips$15,162,669
Others in their field
Other Emerging Leaders on “Macaca Mulatta”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Greg Westergaard · Alpha Genesis Inc$15,926,640
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$12,579,390
- Francois Villinger · University Of Louisiana At Lafayette$12,577,851
- Jacob D Estes · Oregon Health & Science University$12,010,074
- Deanna A Kulpa · Emory University$8,444,989
Research focus
Macaca MulattaAdaptive Immune ResponseIn VivoMacacaAttenuated VaccinesAutomobile DrivingAdjuvantAcquired Immunodeficiency SyndromeAgonistLymphoidCommunicable DiseasesDectin 1Effector T CellEpigenetic ProcessHelper-Inducer T-LymphocyteHematopoietic Stem CellsBiological ModelsImmuneImmune ResponseImmunityInfectionLongevityIn Vitro ModelMacrophage
Grant awards (5)
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2025 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2024 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$599,999
U01 · FY2023 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$567,749
U01 · FY2022 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2021 · AI